According to G1 Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$11.04. In 2022 the company made an earnings per share (EPS) of -HK$26.20 an increase over its 2021 EPS that were of -HK$27.44.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$11.12 | -57.57% |
2022 | -HK$26.20 | -4.53% |
2021 | -HK$27.44 | 34.22% |
2020 | -HK$20.45 | -19.33% |
2019 | -HK$25.34 | 26.36% |
2018 | -HK$20.06 | -10.06% |
2017 | -HK$22.30 | 68.91% |
2016 | -HK$13.20 |